Company Data

Astria Therapeutics Inc.

Ticker
ATXS
Current Price
$3.935 0.38%
Market Cap
$222.1M
Price Target
Refer to Report
Volume
160.5K
52wk Range
$3.555 - $12.92
Advanced Market Data

Overview

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy